- Home
- Publications
- Publication Search
- Publication Details
Title
Current and Emerging Treatment Options for Uterine Fibroids
Authors
Keywords
-
Journal
DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-03
DOI
10.1007/s40265-023-01958-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessing the Hepatic Safety of Epigallocatechin Gallate (EGCG) in Reproductive-Aged Women
- (2023) Hiba Siblini et al. Nutrients
- Progesterone Signaling and Uterine Fibroid Pathogenesis; Molecular Mechanisms and Potential Therapeutics
- (2023) Mohamed Ali et al. Cells
- LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids
- (2023) Ayman Al-Hendy et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Relugolix combination therapy in European women with symptomatic uterine fibroids: a subgroup analysis from the randomized phase 3 LIBERTY pivotal trials
- (2023) Roberta Venturella et al. GYNECOLOGICAL ENDOCRINOLOGY
- An evaluation of relugolix/estradiol/norethindrone acetate for the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women
- (2022) Mohamed Ali et al. EXPERT OPINION ON PHARMACOTHERAPY
- Simvastatin inhibits stem cell proliferation in human leiomyoma via TGF‐β3 and Wnt/β‐Catenin pathways
- (2022) Sadia Afrin et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Simvastatin-loaded liposome nanoparticles treatment for uterine leiomyoma in a patient-derived xenograft mouse model: a pilot study
- (2022) Malak El Sabeh et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis
- (2022) Juliawati Muhammad et al. BMC Womens Health
- The effect of vitamin D on recurrence of uterine fibroids: A randomized, double-blind, placebo-controlled pilot study
- (2022) Mansoureh Vahdat et al. Complementary Therapies in Clinical Practice
- Evaluation of ovulation and safety outcomes in a multi-center randomized trial of three 84 day ulipristal acetate regimens
- (2022) Carolyn L Westhoff et al. CONTRACEPTION
- Short‐term administration of oral relugolix before single‐port laparoscopic‐assisted vaginal hysterectomy for symptomatic uterine myomas: A retrospective comparative study with leuprorelin injection
- (2022) Akihiro Takeda JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- A Review of GnRH Antagonists as Treatment for Abnormal Uterine Bleeding-Leiomyoma (AUB-L) and Their Influence on the Readiness of Service Members
- (2022) Danielle Wright et al. MILITARY MEDICINE
- Relugolix Combination Therapy for Uterine Leiomyoma–Associated Pain in the LIBERTY Randomized Trials
- (2022) Elizabeth A. Stewart et al. OBSTETRICS AND GYNECOLOGY
- Glucocorticoid receptor blockers
- (2022) Mark E. Molitch Pituitary
- Meta-Study of the Clinical Effect of Conservative Treatment in Uterine Fibroids
- (2022) Hanxiao Zhu et al. Journal of Oncology
- Linzagolix: an oral gonadotropin-releasing hormone receptor antagonist treatment for uterine fibroid-associated heavy menstrual bleeding
- (2022) Maria E de Lange et al. LANCET
- Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials
- (2022) Jacques Donnez et al. LANCET
- Simvastatin reduces plasma membrane caveolae and caveolin-1 in uterine leiomyomas
- (2022) Sadia Afrin et al. LIFE SCIENCES
- Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials
- (2022) Elizabeth A. Stewart et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- New local ganirelix sustained release therapy for uterine leiomyoma. Evaluation in a preclinical organ model
- (2022) Ana Salas et al. BIOMEDICINE & PHARMACOTHERAPY
- What is the optimal GnRH antagonist protocol for ovarian stimulation during ART treatment? A systematic review and network meta-analysis
- (2022) C A Venetis et al. HUMAN REPRODUCTION UPDATE
- A Systematic Review of Minimally Invasive Approaches to Uterine Fibroid Treatment for Improving Quality of Life and Fibroid-Associated Symptoms
- (2022) Joshua M. Morris et al. Reproductive Sciences
- Uterine Fibroids, Perceived Stress, and Menstrual Distress: a Key Role of Heavy Menstrual Bleeding
- (2022) Silvia Vannuccini et al. Reproductive Sciences
- Efficacy and Safety of Oral GnRh Antagonists in Patients With Uterine Fibroids: A Systematic Review
- (2022) Rabiya Niaz et al. Journal of Obstetrics and Gynaecology Canada
- What happens after randomised controlled trials? Uterine fibroids and ulipristal acetate: systematic review and meta-analysis of "real-world" data
- (2021) Neha Shah et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Effects of epigallocatechin gallate-enriched green tea extract capsules in uterine myomas: results of an observational study
- (2021) Rebekka Biro et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy
- (2021) Ayman Al-Hendy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Elagolix in the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women
- (2021) Mohamed Ali et al. Expert Review of Clinical Pharmacology
- Oriahnn: New Drug Approved for Treating Heavy Menstrual Bleeding in Women With Uterine Fibroids
- (2021) Sarah E. Lynch et al. ANNALS OF PHARMACOTHERAPY
- Nutraceuticals in fibroid management after ulipristal acetate administration: An observational study on patients’ compliance
- (2021) Andrea Tinelli et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- The comparison of myomectomy, UAE and MRgFUS in the treatment of uterine fibroids: a meta analysis
- (2021) Fan Xu et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Phase III long‐term study to evaluate the efficacy and safety of ulipristal acetate in Japanese patients with uterine fibroids
- (2021) Yutaka Osuga et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Understanding the Impact of Uterine Fibroids on Human Endometrium Function
- (2021) Antonia Navarro et al. Frontiers in Cell and Developmental Biology
- Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment
- (2021) Qiwei Yang et al. ENDOCRINE REVIEWS
- Current approaches to overcome the side effects of GnRH analogs in the treatment of patients with uterine fibroids
- (2021) Mohamed Ali et al. Expert Opinion On Drug Safety
- Vitamin D and green tea extracts for the treatment of uterine fibroids in late reproductive life: a pilot, prospective, daily-diary based study
- (2021) Giovanni Grandi et al. GYNECOLOGICAL ENDOCRINOLOGY
- Oral Gonadotropin-Releasing Hormone Antagonists in the Treatment of Uterine Myomas: A Systematic Review and Network Meta-analysis of Efficacy Parameters and Adverse Effects
- (2021) Savci Bekir Telek et al. Journal of Minimally Invasive Gynecology
- Reduction of Heavy Menstrual Bleeding in Women Not Designated as Responders to Elagolix Plus Add Back Therapy for Uterine Fibroids
- (2021) Elizabeth A. Stewart et al. JOURNAL OF WOMENS HEALTH
- Simvastatin modulates estrogen signaling in uterine leiomyoma via regulating receptor palmitoylation, trafficking and degradation
- (2021) Sadia Afrin et al. PHARMACOLOGICAL RESEARCH
- Relugolix for oral treatment of uterine leiomyomas: a dose-finding, randomized, controlled trial
- (2021) Hiroshi Hoshiai et al. BMC Womens Health
- Conservative Management of Uterine Fibroid-Related Heavy Menstrual Bleeding and Infertility: Time for a Deeper Mechanistic Understanding and an Individualized Approach
- (2021) Marie-Madeleine Dolmans et al. Journal of Clinical Medicine
- Ulipristal acetate simultaneously provokes antiproliferative and proinflammatory responses in endometrial cancer cells
- (2021) Ranka Kanda et al. Heliyon
- The Biological Impact Of Ulipristal Acetate On Cellular Networks Regulating Uterine Leiomyoma Growth.
- (2020) Andrea Tinelli et al. CURRENT PHARMACEUTICAL DESIGN
- Vitamin D and uterine fibroids: preclinical evidence is in; time for an overdue clinical study!
- (2020) Mohamed Ali et al. FERTILITY AND STERILITY
- Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids
- (2020) William D. Schlaff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intraoperative Tranexamic Acid to Decrease Blood Loss During Myomectomy: A Randomized Double-Blind Placebo Controlled Trial
- (2020) Jessica Opoku-Anane et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Simvastatin ameliorates altered mechanotransduction in uterine leiomyoma cells
- (2020) Sadia Afrin et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Comparison of high‐intensity focused ultrasound ablation and secondary myomectomy for recurrent symptomatic uterine fibroids following myomectomy: a retrospective study
- (2020) X Liu et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Selective progesterone receptor modulators-mechanisms and therapeutic utility
- (2020) Md Soriful Islam et al. ENDOCRINE REVIEWS
- Efficacy and safety of vilaprisan in women with uterine fibroids: Data from the phase 2b randomized controlled trial ASTEROID 2
- (2020) Kristina Gemzell-Danielsson et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- An update on vitamin D signaling and cancer
- (2020) Carsten Carlberg et al. SEMINARS IN CANCER BIOLOGY
- Evaluation of goserelin effectiveness based on assessment of inflammatory cytokines and symptoms in uterine leiomyoma
- (2020) Nadia H. Mohammed et al. International Journal of Clinical Pharmacy
- Effect of oral consumption of vitamin D on uterine fibroids: A randomized clinical trial
- (2020) Somayye Arjeh et al. Complementary Therapies in Clinical Practice
- 90 YEARS OF PROGESTERONE: Selective progesterone receptor modulators in gynaecological therapies
- (2020) H O D Critchley et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas
- (2020) James A. Simon et al. OBSTETRICS AND GYNECOLOGY
- Ulipristal acetate versus gonadotropin-releasing hormone agonists prior to laparoscopic myomectomy (MYOMEX trial): Long term results of a double-blind randomized controlled trial
- (2020) Inge De Milliano et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain in a dose–response manner: a randomized, double-blind, placebo-controlled study
- (2020) Yutaka Osuga et al. FERTILITY AND STERILITY
- LINZAGOLIX MAY ADDRESS THE LONG-TERM TREATMENT NEEDS OF WOMEN WITH UTERINE FIBROIDS (UF) WHO HAVE CONTRAINDICATIONS TO HORMONAL ADD-BACK THERAPY (ABT): RESULTS FROM TWO PHASE 3 RANDOMIZED CLINICAL TRIALS
- (2020) Linda D. Bradley et al. FERTILITY AND STERILITY
- Selective estrogen receptor modulator with estrogen does not affect the proliferation and apoptosis of uterine leiomyoma cells
- (2020) Shu-Lan Lv et al. Translational Cancer Research
- Risk–efficacy balance of ulipristal acetate compared to surgical alternatives
- (2020) Mei‐An Middelkoop et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Compared With Leuprorelin Injections for Uterine Leiomyomas
- (2019) Yutaka Osuga et al. OBSTETRICS AND GYNECOLOGY
- Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials
- (2019) E A Stewart et al. HUMAN REPRODUCTION
- Ulipristal acetate decreases active TGF-β3 and its canonical signaling in uterine leiomyoma via two novel mechanisms
- (2019) Terrence D. Lewis et al. FERTILITY AND STERILITY
- Health-Related Quality of Life With Ulipristal Acetate for Treatment of Uterine Leiomyomas
- (2019) Andrea S. Lukes et al. OBSTETRICS AND GYNECOLOGY
- Vitamin D3 and its analogue paricalcitol reverse DNA damage in human uterine fibroid stem cells: mechanism for potential preventive therapy
- (2019) Mohamed Ali B.Pharm et al. FERTILITY AND STERILITY
- Relugolix, a novel oral gonadotropin-releasing hormone antagonist, in the treatment of pain symptoms associated with uterine fibroids: a randomized, placebo-controlled, phase 3 study in Japanese women
- (2019) Yutaka Osuga et al. FERTILITY AND STERILITY
- The Selective Progesterone Receptor Modulator Ulipristal Acetate Inhibits the Activity of the Glucocorticoid Receptor
- (2019) Benjamin Small et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Autophagy up-regulation by ulipristal acetate as a novel target mechanism in the treatment of uterine leiomyoma: an in vitro study
- (2019) Barbara Del Bello et al. FERTILITY AND STERILITY
- Matrix Metalloproteinase Activity Correlates With Uterine Myoma Volume Reduction After Ulipristal Acetate Treatment
- (2018) Guillaume E Courtoy et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Ulipristal Acetate for Treatment of Symptomatic Uterine Leiomyomas
- (2018) James A. Simon et al. OBSTETRICS AND GYNECOLOGY
- A Comprehensive Review of the Pharmacologic Management of Uterine Leiomyoma
- (2018) Terrence D. Lewis et al. Biomed Research International
- Ulipristal Acetate Interferes With Actin Remodeling Induced by 17β-Estradiol and Progesterone in Human Endometrial Stromal Cells
- (2018) Jorge E. Shortrede et al. Frontiers in Endocrinology
- Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of US Women
- (2018) Erica E. Marsh et al. JOURNAL OF WOMENS HEALTH
- FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery
- (2018) Shannon Laughlin-Tommaso et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Simvastatin, at clinically relevant concentrations, affects human uterine leiomyoma growth and extracellular matrix production
- (2018) Minnie Malik et al. FERTILITY AND STERILITY
- Vilaprisan in women with uterine fibroids: the randomized phase 2b ASTEROID 1 study
- (2018) Linda D. Bradley et al. FERTILITY AND STERILITY
- The Role of Tumor Necrosis Factor α in the Biology of Uterine Fibroids and the Related Symptoms
- (2018) Michał Ciebiera et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas
- (2018) Bruce R. Carr et al. OBSTETRICS AND GYNECOLOGY
- 1,25 Dihydroxyvitamin D3 Enhances the Antifibroid Effects of Ulipristal Acetate in Human Uterine Fibroids
- (2018) Mohamed Ali et al. Reproductive Sciences
- Real world data of 1473 patients treated with ulipristal acetate for uterine fibroids: Premya study results
- (2017) Hervé Fernandez et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Successes and failures of uterine leiomyoma drug discovery
- (2017) Mohamed Ali et al. Expert Opinion on Drug Discovery
- Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study
- (2017) David F. Archer et al. FERTILITY AND STERILITY
- Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist
- (2017) Hugh S. Taylor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ulipristal Acetate and Extracellular Matrix Production in Human Leiomyomas In Vivo: A Laboratory Analysis of a Randomized Placebo Controlled Trial
- (2017) Jeris Cox et al. Reproductive Sciences
- Current and Emerging Medical Treatments for Uterine Fibroids
- (2017) Hugh Taylor et al. SEMINARS IN REPRODUCTIVE MEDICINE
- Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study
- (2016) Mostafa A. Borahay et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Mifepristone inhibits extracellular matrix formation in uterine leiomyoma
- (2016) Amrita Patel et al. FERTILITY AND STERILITY
- Long-term medical management of uterine fibroids with ulipristal acetate
- (2016) Jacques Donnez et al. FERTILITY AND STERILITY
- Pharmacodynamics and safety of the novel selective progesterone receptor modulator vilaprisan: a double-blind, randomized, placebo-controlled phase 1 trial in healthy women
- (2016) Barbara Schütt et al. HUMAN REPRODUCTION
- Biological and Mechanistic Characterization of Novel Prodrugs of Green Tea Polyphenol Epigallocatechin Gallate Analogs in Human Leiomyoma Cell Lines
- (2016) Reda Saber Ibrahim Ahmed et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Hypovitaminosis D and “small burden” uterine fibroids
- (2016) Andrea Ciavattini et al. MEDICINE
- Paxillin, a novel controller in the signaling of estrogen to FAK/N-WASP/Arp2/3 complex in breast cancer cells
- (2016) Jorge Eduardo Shortrede et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Uterine fibroids
- (2016) Elizabeth A. Stewart et al. Nature Reviews Disease Primers
- Novel effects of simvastatin on uterine fibroid tumors: in vitro and patient-derived xenograft mouse model study
- (2015) Mostafa A. Borahay et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Current management of myomas
- (2015) Jacques Donnez et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Three-month treatment with triptorelin, letrozole and ulipristal acetate before hysteroscopic resection of uterine myomas: prospective comparative pilot study
- (2015) Nicolò Bizzarri et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Leiomyoma-derived transforming growth factor-β impairs bone morphogenetic protein-2-mediated endometrial receptivity
- (2015) Leo F. Doherty et al. FERTILITY AND STERILITY
- Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids
- (2015) Jacques Donnez et al. FERTILITY AND STERILITY
- In vivo mechanisms of uterine myoma volume reduction with ulipristal acetate treatment
- (2015) Guillaume E. Courtoy et al. FERTILITY AND STERILITY
- Stro-1/CD44 as putative human myometrial and fibroid stem cell markers
- (2015) Aymara Mas et al. FERTILITY AND STERILITY
- Role of vitamin D in uterine fibroid biology
- (2015) Soumia Brakta et al. FERTILITY AND STERILITY
- Human Uterine Leiomyoma Stem/Progenitor Cells Expressing CD34 and CD49b Initiate Tumors In Vivo
- (2015) Ping Yin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Low-Dose Mifepristone Versus Placebo to Treat Uterine Myoma: A Double-Blind, Randomized Clinical Trial
- (2015) C Liu Journal of Minimally Invasive Gynecology
- MED12 exon 2 mutations are common in uterine leiomyomas from South African patients
- (2015) Netta Mäkinen et al. Oncotarget
- The activity of catechol-O-methyltransferase (COMT) is not impaired by high doses of epigallocatechin-3-gallate (EGCG) in vivo
- (2014) Mario Lorenz et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Long-term treatment of uterine fibroids with ulipristal acetate☆
- (2014) Jacques Donnez et al. FERTILITY AND STERILITY
- Green Tea Extract Inhibition of Human Leiomyoma Cell Proliferation Is Mediated via Catechol-O-Methyltransferase
- (2014) Dong Zhang et al. GYNECOLOGIC AND OBSTETRIC INVESTIGATION
- Mutations in Exon 1 Highlight the Role ofMED12in Uterine Leiomyomas
- (2014) Kati Kämpjärvi et al. HUMAN MUTATION
- Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications
- (2014) Molly B. Moravek et al. HUMAN REPRODUCTION UPDATE
- Simvastatin Potently Induces Calcium-dependent Apoptosis of Human Leiomyoma Cells
- (2014) Mostafa A. Borahay et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Novel MED12 gene somatic mutations in women from the Southern United States with symptomatic uterine fibroids
- (2014) Sunil K. Halder et al. MOLECULAR GENETICS AND GENOMICS
- Quantitative Serial MRI of the Treated Fibroid Uterus
- (2014) Kirsty I. Munro et al. PLoS One
- Paricalcitol, a Vitamin D Receptor Activator, Inhibits Tumor Formation in a Murine Model of Uterine Fibroids
- (2014) Sunil K. Halder et al. Reproductive Sciences
- Ulipristal Acetate Modulates the Expression and Functions of Activin A in Leiomyoma Cells
- (2014) Pasquapina Ciarmela et al. Reproductive Sciences
- Transforming growth factor β signaling in uterine development and function
- (2014) Qinglei Li Journal of Animal Science and Biotechnology
- Tranexamic acid for the management of uterine fibroid tumors: A systematic review of the current evidence
- (2014) Panagiotis Peitsidis World Journal of Clinical Cases
- Vitamin D and the Risk of Uterine Fibroids
- (2013) Donna Day Baird et al. EPIDEMIOLOGY
- Complex networks of multiple factors in the pathogenesis of uterine leiomyoma
- (2013) Md Soriful Islam et al. FERTILITY AND STERILITY
- Effects of mifepristone on uterine leiomyoma in premenopausal women: a meta-analysis
- (2013) Qi Shen et al. FERTILITY AND STERILITY
- BAY 1002670: a novel, highly potent and selective progesterone receptor modulator for gynaecological therapies
- (2013) A. Wagenfeld et al. HUMAN REPRODUCTION
- A Trial to Cryopreserve Immature Medaka (Oryzias latipes) Oocytes after Enhancing Their Permeability by Exogenous Expression of Aquaporin 3
- (2013) Delgado M. VALDEZ JR. et al. JOURNAL OF REPRODUCTION AND DEVELOPMENT
- Characterization of Uterine Leiomyomas by Whole-Genome Sequencing
- (2013) Miika Mehine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Paracrine activation of WNT/ -catenin pathway in uterine leiomyoma stem cells promotes tumor growth
- (2013) M. Ono et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Racial and Ethnic Differences in the Pathogenesis and Clinical Manifestations of Uterine Leiomyoma
- (2013) William Catherino et al. SEMINARS IN REPRODUCTIVE MEDICINE
- 1,25-Dihydroxyvitamin D3 Treatment Shrinks Uterine Leiomyoma Tumors in the Eker Rat Model1
- (2012) Sunil K. Halder et al. BIOLOGY OF REPRODUCTION
- Prediction of the shrinking rate of uterine leiomyoma nodules using needle biopsy specimens
- (2012) Mari Kasai et al. FERTILITY AND STERILITY
- Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production
- (2012) Joy Lynne Britten et al. FERTILITY AND STERILITY
- Ulipristal Acetate versus Placebo for Fibroid Treatment before Surgery
- (2012) Jacques Donnez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ulipristal Acetate versus Leuprolide Acetate for Uterine Fibroids
- (2012) Jacques Donnez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Whole Exome Sequencing in a Random Sample of North American Women with Leiomyomas Identifies MED12 Mutations in Majority of Uterine Leiomyomas
- (2012) Megan M. McGuire et al. PLoS One
- Role of Stem Cells in Human Uterine Leiomyoma Growth
- (2012) Masanori Ono et al. PLoS One
- Evolution of Minimal Specificity and Promiscuity in Steroid Hormone Receptors
- (2012) Geeta N. Eick et al. PLoS Genetics
- The estimated annual cost of uterine leiomyomata in the United States
- (2011) Eden R. Cardozo et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Gonadotropin-releasing hormone agonist increases expression of osmotic response genes in leiomyoma cells
- (2011) Desireé M. McCarthy-Keith et al. FERTILITY AND STERILITY
- Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications
- (2011) Pasquapina Ciarmela et al. HUMAN REPRODUCTION UPDATE
- MED12, the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas
- (2011) N. Makinen et al. SCIENCE
- A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia
- (2010) Gamal H. Sayed et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Leiomyoma Simultaneously Impair Endometrial BMP-2-Mediated Decidualization and Anticoagulant Expression through Secretion of TGF-β3
- (2010) Donna C. Sinclair et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Tranexamic Acid Treatment for Heavy Menstrual Bleeding
- (2010) Andrea S. Lukes et al. OBSTETRICS AND GYNECOLOGY
- Treatment of symptomatic uterine leiomyoma with letrozole
- (2010) Bilgin Gurates et al. REPRODUCTIVE BIOMEDICINE ONLINE
- Cell-Type Specific Actions of Progesterone Receptor Modulators in the Regulation of Uterine Leiomyoma Growth
- (2010) Shigeki Yoshida et al. SEMINARS IN REPRODUCTIVE MEDICINE
- Proinflammatory and Profibrotic Mediators: Principal Effectors of Leiomyoma Development as a Fibrotic Disorder
- (2010) Nasser Chegini SEMINARS IN REPRODUCTIVE MEDICINE
- Clinical utility of progesterone receptor modulators and their effect on the endometrium
- (2009) Irving M Spitz CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- GnRH antagonist, cetrorelix, for pituitary suppression in modern, patient-friendly assisted reproductive technology
- (2009) Ilan Tur-Kaspa et al. Expert Opinion on Drug Metabolism & Toxicology
- A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status
- (2009) Mohammad Ebrahim Parsanezhad et al. FERTILITY AND STERILITY
- Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial
- (2009) M. Engman et al. HUMAN REPRODUCTION
- Differential actions of estrogen and SERMs in regulation of the actin cytoskeleton of endometrial cells
- (2009) M.I. Flamini et al. MOLECULAR HUMAN REPRODUCTION
- Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients
- (2008) Sandro G. Hilário et al. FERTILITY AND STERILITY
- Vitamin D inhibits myometrial and leiomyoma cell proliferation in vitro
- (2008) Merja Bläuer et al. FERTILITY AND STERILITY
- Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells
- (2008) Q. Xu et al. MOLECULAR HUMAN REPRODUCTION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started